NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

iSpecimen logo
$0.46 -0.07 (-13.58%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.47 +0.02 (+3.44%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About iSpecimen Stock (NASDAQ:ISPC)

Advanced

Key Stats

Today's Range
$0.43
▼
$0.53
50-Day Range
$0.46
▼
$1.47
52-Week Range
$0.43
▼
$27.44
Volume
150,786 shs
Average Volume
280,052 shs
Market Capitalization
$1.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

iSpecimen, Inc. operates an online marketplace that connects life-science researchers with hospitals, laboratories, biobanks and other providers of human biospecimens. Its platform is designed to help researchers find and request samples for medical and scientific research.

Through its iSpecimen Marketplace, the company facilitates access to materials such as blood, tissue and other human specimens, along with associated data when available. It also supports the coordination of specimen sourcing and fulfillment between research organizations and providers.

Founded in 2009 by Christopher Ianelli, iSpecimen has built a network intended to serve research organizations and specimen providers in the United States and internationally.

AI Generated. May Contain Errors.

iSpecimen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

ISPC MarketRank™: 
0.28685650161 of 5 stars

iSpecimen scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iSpecimen has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    iSpecimen has only been the subject of 1 research reports in the past 90 days.

  • Read more about iSpecimen's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iSpecimen is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iSpecimen is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iSpecimen has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    13.80% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.74, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently increased by 92.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iSpecimen does not currently pay a dividend.

  • Dividend Growth

    iSpecimen does not have a long track record of dividend growth.

  • News Sentiment

    iSpecimen has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for iSpecimen this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added iSpecimen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iSpecimen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    13.62% of the stock of iSpecimen is held by institutions.

  • Read more about iSpecimen's insider trading history.
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISPC Stock News Headlines

iSpecimen (NASDAQ:ISPC) Stock to Reverse Split on Tuesday, November 24th
iSpecimen Reports Delay in Its Quarterly Filing
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
iSpecimen to Acquire Foldlab AI Disease Analytics
iSpecimen Engages IR Agency for Investor Marketing
See More Headlines

ISPC Stock Analysis - Frequently Asked Questions

iSpecimen's stock was trading at $10.4040 at the start of the year. Since then, ISPC stock has decreased by 95.6% and is now trading at $0.4563.

iSpecimen Inc. (NASDAQ:ISPC) released its earnings results on Tuesday, November, 17th. The company reported ($1.03) EPS for the quarter. The company earned $244.03 thousand during the quarter. iSpecimen had a negative trailing twelve-month return on equity of 447.19% and a negative net margin of 1,796.52%.

iSpecimen's stock reverse split on Tuesday, November 24th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders will be adjusted after the market closes on Monday, November 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

iSpecimen (ISPC) raised $20 million in an IPO on Tuesday, June 15th 2021. The company issued 2,250,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include Advanced Micro Devices (AMD), NIO (NIO), Biofrontera (BFRI), NVIDIA (NVDA), Palantir Technologies (PLTR), Longeveron (LGVN) and AST SpaceMobile (ASTS).

Company Calendar

Last Earnings
11/17/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:ISPC
CIK
1558569
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($38.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.49 million
Net Margins
-1,796.52%
Pretax Margin
-1,796.69%
Return on Equity
-447.19%
Return on Assets
-130.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.16
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$466.30 thousand
Price / Sales
2.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.62 per share
Price / Book
0.28

Miscellaneous

Outstanding Shares
2,519,000
Free Float
2,212,000
Market Cap
$1.15 million
Optionable
Not Optionable
Beta
1.54
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:ISPC) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners